These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32053085)

  • 81. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
    Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
    J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
    Chen W; Cheng CA; Zink JI
    ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Investigation of novel superparamagnetic Ni
    Qasim M; Asghar K; Dharmapuri G; Das D
    Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis.
    Yan J; Chen J; Zhang N; Yang Y; Zhu W; Li L; He B
    J Mater Chem B; 2020 Jan; 8(3):492-503. PubMed ID: 31840727
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods.
    Zhang Z; Wang J; Nie X; Wen T; Ji Y; Wu X; Zhao Y; Chen C
    J Am Chem Soc; 2014 May; 136(20):7317-26. PubMed ID: 24773323
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment.
    Caldera F; Argenziano M; Trotta F; Dianzani C; Gigliotti L; Tannous M; Pastero L; Aquilano D; Nishimoto T; Higashiyama T; Cavalli R
    Carbohydr Polym; 2018 Aug; 194():111-121. PubMed ID: 29801818
    [TBL] [Abstract][Full Text] [Related]  

  • 87. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique.
    Dey C; Ghosh A; Ahir M; Ghosh A; Goswami MM
    Chemphyschem; 2018 Nov; 19(21):2872-2878. PubMed ID: 30133086
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A convergent synthetic platform for dual anticancer drugs functionalized by reduced graphene nanocomposite delivery for hepatocellular cancer.
    Zhang Z; Su T; Han Y; Yang Z; Wei J; Jin L; Fan H
    Drug Deliv; 2021 Dec; 28(1):1982-1994. PubMed ID: 34569406
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ion-induced fabrication of silk fibroin nanoparticles from Chinese oak tasar Antheraea pernyi.
    Wang J; Zhang S; Xing T; Kundu B; Li M; Kundu SC; Lu S
    Int J Biol Macromol; 2015 Aug; 79():316-25. PubMed ID: 25936281
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model.
    Yoncheva K; Merino M; Shenol A; Daskalov NT; Petkov PS; Vayssilov GN; Garrido MJ
    Int J Pharm; 2019 Feb; 556():1-8. PubMed ID: 30529664
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Functionalized Graphene Oxide with Hepatocyte Targeting as Anti-Tumor Drug and Gene Intracellular Transporters.
    Cao X; Zheng S; Zhang S; Wang Y; Yang X; Duan H; Huang Y; Chen Y
    J Nanosci Nanotechnol; 2015 Mar; 15(3):2052-9. PubMed ID: 26413620
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
    Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
    Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide.
    Sodano F; Cavanagh RJ; Pearce AK; Lazzarato L; Rolando B; Fraix A; Abelha TF; Vasey CE; Alexander C; Taresco V; Sortino S
    Biomater Sci; 2020 Mar; 8(5):1329-1344. PubMed ID: 31912808
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Photoresponsive transformation from spherical to nanotubular assemblies: anticancer drug delivery using macrocyclic cationic gemini amphiphiles.
    Dey S; Chatterjee S; Patel A; Pradhan N; Srivastava D; Patra N; Bhattacharyya A; Manna D
    Chem Commun (Camb); 2021 May; 57(38):4646-4649. PubMed ID: 33881081
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A perfect stimuli-responsive magnetic nanocomposite for intracellular delivery of doxorubicin.
    Ghamkhari A; Ghorbani M; Aghbolaghi S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S911-S921. PubMed ID: 30307331
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Doxorubicin-loaded Fe
    Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
    J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Incorporation of magnetic NaX zeolite/DOX into the PLA/chitosan nanofibers for sustained release of doxorubicin against carcinoma cells death in vitro.
    Abasian P; Radmansouri M; Habibi Jouybari M; Ghasemi MV; Mohammadi A; Irani M; Jazi FS
    Int J Biol Macromol; 2019 Jan; 121():398-406. PubMed ID: 30287373
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy.
    SreeHarsha N; Maheshwari R; Al-Dhubiab BE; Tekade M; Sharma MC; Venugopala KN; Tekade RK; Alzahrani AM
    Int J Nanomedicine; 2019; 14():7419-7429. PubMed ID: 31686814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.